G20210A Prothrombin gene variant in Turkish patients with angiographically documented coronary artery disease

Journal of Thrombosis and Thrombolysis

Volumn 24, Issue 3, 2007, Pages 255-259

  Gundogdu, Fuat ^a   Gurlertop, Yekta ^a   Pirim, Ibrahim ^a   Arslan, Sakir ^a   Ikbal, Mevlut ^a   Islamoglu, Yahya ^a   Aksoy, Hulya ^a   Senocak, Huseyin ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Coronary angiography; Coronary artery disease; G20210A prothrombin variant

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTHROMBIN; TRIACYLGLYCEROL;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DNA DETERMINATION; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SMOKING; TURKEY (REPUBLIC);

AGED; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROTHROMBIN; TURKEY;

EID: 35448942261     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-007-0019-7     Document Type: Article

References (31)

1. Jackson CM (1978) The biochemistry of prothrombin activation. Br J Haematol 39(1):1-8
2. Royle NJ, Irwin DM, Koschinsky ML, MacGillivray RT, Hamerton JL (1987) Human genes encoding prothrombin and ceruloplasmin map to 11p11-q12 and 3q21-24, respectively. Somat Cell Mol Genet 13(3):285-292
3. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88(10):3698-3703
4. Andreotti F, Burzotta F, De Stefano V, Maseri A, Iacoviello L (2000) The G20210A prothrombin mutation and the Physicians' Health Study. Circulation 101(21):E207-E208
5. Rosendaal FR, Doggen CJ, Zivelin A et al (1998) Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 79(4):706-708
6. Gupta N, Khan F, Tripathi M et al (2003) Absence of factor V Leiden (G1691A) mutation, FII G20210A allele in coronary artery disease in North India. Indian J Med Sci 57(12):535-542
7. Arruda VR, Siquiera LH, Chiaparini LC et al (1998) Prevalence of the prothrombin gene variant 20210 G Y → A among patients with myocardial infarction. Cardiovasc Res 37(1):42-45
8. Burzotta F, Paciaroni K, De Stefano V et al (2002) Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease. Eur Heart J 23(1):26-30
9. Russo C, Girelli D, Olivieri O et al (2001) G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease. Circulation 103(20):2436-2440
10. Abu-Amero KK, Wyngaard CA, Kambouris M, Dzimiri N. (2002) Prevalence of the 20210 G → A prothrombin variant and its association with coronary artery disease in a Middle Eastern Arab population. Arch Pathol Lab Med 126(9):1087-1090
11. Cumming AM, Keeney S, Salden A, Bhavnani M, Shwe KH, Hay CR (1997) The prothrombin gene G20210A variant: Prevalence in a UK anticoagulant clinic population. Br J Haematol 98(2):353-355
12. Brown K, Luddington R, Williamson D, Baker P, Baglin T (1997) Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene. Br J Haematol 98(4):907-909
13. Makris M, Preston FE, Beauchamp NJ et al (1997) Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost 78(6):1426-1429
14. Watzke HH, Schuttrumpf J, Graf S, Huber K, Panzer S (1997) Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease. Thromb Res 87(6):521-526
15. Doggen CJ, Cats VM, Bertina RM, Rosendaal FR (1998) Interaction of coagulation defects and cardiovascular risk factors: Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 97(11):1037-1041
16. Corral J, Gonzalez-Conejero R, Lozano ML, Rivera J, Heras I, Vicente V (1997) The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease. Br J Haematol 99(2):304-307
17. Hillarp A, Zoller B, Svensson PJ, Dahlback B (1997) The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 78(3):990-992
18. Ferraresi P, Marchetti G, Legnani C et al (1997) The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler Thromb Vasc Biol 17(11):2418-2422
19. Gurgey A, Unal S, Okur H, Duru F, Gumruk F (2005) Prothrombin G20210A mutation in Turkish children with thrombosis and the frequency of prothrombin C20209T. Pediatr Hematol Oncol 22(4):309-314. Erratum in: Pediatr Hematol Oncol 22(6):541-542
20. Donmez Y, Kanadasi M, Tanriverdi K et al (2004) Prothrombin 20210GA and factor V Leiden mutations in patients less than 55 years old with myocardial infarction. Jpn Heart J 45(3):505-512
21. Folsom AR, Cushman M, Tsai MY, Heckbert SR, Aleksic N (2002) Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism. Am J Hematol 71(4):285-290
22. Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD (1996) Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost 75(5):767-771
23. Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL (1997) A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 90(5):1747-1750
24. Van de Water NS, French JK, Lund M, Hyde TA, White HD, Browett PJ (2000) Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50 years with no significant stenoses at angiography 3-4 weeks after myocardial infarction. J Am Coll Cardiol 36(3):717-722
25. Coulet F, Godard V, Verdy E, Soubrier F (2000) Lack of association of the prothrombin gene variant G20210A with myocardial infarction in Caucasian males. Thromb Haemost 83(5):796-797
26. Croft SA, Daly ME, Steeds RP, Channer KS, Samani NJ, Hampton KK (1999) The prothrombin 20210A allele and its association with myocardial infarction. Thromb Haemost 81(6):861-864
27. Tanis BC, Bloemenkamp DG, van den Bosch MA et al (2003) Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction. Br J Haematol 122(3):471-478
28. Eikelboom JW, Baker RI, Parsons R, Taylor RR, van Bockxmeer FM (1998) No association between the 20210 G/A prothrombin gene mutation and premature coronary artery disease. Thromb Haemost 80(6):878-880
29. Prohaska W, Schmidt M, Mannebach H, Gleichmann U, Kleesiek K (1999) The prevalence of the prothrombin 20210 G → A mutation is not increased in angiographically confirmed coronary artery disease. Thromb Haemost 81(1):161-162
30. Ridker PM, Hennekens CH, Miletich JP (1999) G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 99(8):999-1004
31. Lander ES, Schork NJ (1994) Genetic dissection of complex traits. Science 265(5181):2037-2048. Review. Erratum in: Science 266(5184):353